The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
